Patent · US Active

Sulcardine administration for treatment of acute atrial fibrillation

US11364223B2 · kind B2 · utility

1Cited by
6References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 2019
Grant dateJun 21, 2022
Priority date—
Expiry dateDec 12, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compositions and methods for administration of sulcardine to a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.